Reported Standalone quarterly numbers for Vaishali Pharma are:
Net Sales at Rs 32.25 crore in March 2025 down 0.46% from Rs. 32.40 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 4.29 crore in March 2025 up 8.33% from Rs. 4.68 crore in March 2024.
EBITDA stands negative at Rs. 5.04 crore in March 2025 up 14.29% from Rs. 5.88 crore in March 2024.
Vaishali Pharma shares closed at 12.58 on June 11, 2025 (NSE) and has given -36.37% returns over the last 6 months and -20.83% over the last 12 months.
Story continues below Advertisement
| Vaishali Pharma | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 31.61 | 27.91 | 32.40 | | Other Operating Income | 0.63 | -- | -- | | Total Income From Operations | 32.25 | 27.91 | 32.40 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 31.29 | 26.00 | 31.82 | | Increase/Decrease in Stocks | -0.65 | -2.27 | 0.49 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.74 | 0.63 | 0.63 | | Depreciation | 0.12 | 0.12 | 0.14 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 6.90 | 2.18 | 6.23 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -6.16 | 1.24 | -6.92 | | Other Income | 1.00 | 1.07 | 0.91 | | P/L Before Int., Excpt. Items & Tax | -5.16 | 2.31 | -6.02 | | Interest | 0.44 | 0.38 | 0.40 | | P/L Before Exceptional Items & Tax | -5.60 | 1.93 | -6.42 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.60 | 1.93 | -6.42 | | Tax | -1.31 | 0.48 | -1.73 | | P/L After Tax from Ordinary Activities | -4.29 | 1.44 | -4.68 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -4.29 | 1.44 | -4.68 | | Equity Share Capital | 26.09 | 13.05 | 10.72 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.17 | 0.22 | -4.37 | | Diluted EPS | -3.17 | 0.22 | -4.17 | | EPS After Extra Ordinary | | Basic EPS | -3.17 | 0.22 | -4.37 | | Diluted EPS | -3.17 | 0.22 | -4.17 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
